Eli Lilly cuts cash prices of Zepbound weight loss drug vials on direct-to-consumer site
LillyLilly(US:LLY) CNBC Television·2025-12-01 22:00

But what Lily is trying to do today is stay competitive in the direct to consumer space for its weight loss drugs, especially following similar moves by Nova Nordis two weeks ago. And so what Lily is doing today is specifically cutting the cash price of single dose vials of Zepbound on its direct to consumer website, Lily Direct. Okay.And what's different with this compared to the Trump deal is that the Trump deal focuses on a totally different form of Zepbound, which is a multi-dosese pen that has yet to w ...